Search through all our worldwide HIV and AIDS news and features, using the topics below to filter your results by subjects including HIV treatment, transmission and prevention, and hepatitis and TB co-infections.

Tuberculosis and HIV news

Show

From To
South Africa death rates declined due to HIV success – report

Death rates have declined, largely due to successes in HIV, but a lot more needs to be done to defeat its “terrible twin”, tuberculosis (TB).

Published
16 hours ago
From
Health-e
X-DR TB emerged in 1990s in South Africa fueled by HIV

Extensively drug resistant tuberculosis emerged and was widely transmitted in South Africa long before it was spotted by public health surveillance efforts, and at least a decade earlier than the first reported outbreak in 2005, a  presentation Monday showed.

Published
26 July 2017
From
Science Speaks
WHO recommends package of tests, treatment and prevention for 'urgent need' people with HIV with low CD4 counts

A new package of measures to ensure rapid initiation of antiretroviral treatment and diagnosis of opportunistic infections has been recommended by the World Health Organization (WHO) to

Published
23 July 2017
By
Keith Alcorn
The 2017 Pipeline Report

Treatment Action Group (TAG) announces the launch of its annual research and development landscape analysis: The Pipeline Report: Drugs, Diagnostics, Vaccines, Preventive Technologies, Research Toward a Cure, and Immune-Based and Gene Therapies in Development.

Published
19 July 2017
From
Treatment Action Group
We had to run our own trial for TB drugs – nobody else was doing it

Four years ago, Médecins Sans Frontières (MSF) made the decision to sponsor and run its own tuberculosis clinical trial. The aim was to find a new treatment regimen for drug-resistant tuberculosis (TB) that was radically better than what was currently available. As an organisation that specialises in delivering short-term emergency healthcare, this was a bold and new direction to take. But it was a decision that came from our frustration, anger and impatience on behalf of the more than 20,000 people with TB that we treat every year. We felt compelled to search for improved treatments ourselves because too few pharmaceutical companies, organisations or universities were doing enough about it.

Published
02 June 2017
From
The Guardian
MDR-TB numbers could keep growing despite improved treatment

Up to one-in-three tuberculosis cases in Russia could be multidrug resistant by 2040, and one-in-eight in India, unless more is done to stop the person-to-person

Published
11 May 2017
By
Keith Alcorn
TB/HIV outreach finding patients in remote South Africa

A novel tuberculosis and HIV case-finding method effectively detected people with both diseases in a remote area of South Africa, according to researchers.

Published
10 May 2017
From
Healio
Multidrug-resistant tuberculosis in migrants, multi-country cluster

A multi-country cluster of multidrug-resistant tuberculosis (MDR TB) involving 28 migrants has been delineated by whole genome sequencing (WGS) in migrants recently having arrived from countries in the Horn of Africa. Although the number of cases detected so far is small, there is a possibility that more cases associated with this cluster may still be identified.

Published
14 April 2017
From
ECDC
Health system navigators didn't improve ART initiation or TB treatment completion rates among people newly diagnosed with HIV in Durban

An intervention using health system navigators, phone support and text message reminders did not improve rates of people living with HIV initiating antiretroviral therapy (ART) or completing treatment

Published
10 April 2017
By
Michael Carter
South Africa: 'We Can't Accept the New HIV, TB Plan' - Treatment Action Campaign

The new national strategic plan for HIV and TB is a plan that seems reasonable when considered in the abstract, but that risks falling apart when confronted by the realities of the public healthcare system and political context.

Published
04 April 2017
From
AllAfrica
← First12345...105Next →

Filter by country

Community Consensus Statement on Access to HIV Treatment and its Use for Prevention

Together, we can make it happen

We can end HIV soon if people have equal access to HIV drugs as treatment and as PrEP, and have free choice over whether to take them.

Launched today, the Community Consensus Statement is a basic set of principles aimed at making sure that happens.

The Community Consensus Statement is a joint initiative of AVAC, EATG, MSMGF, GNP+, HIV i-Base, the International HIV/AIDS Alliance, ITPC and NAM/aidsmap
close

This content was checked for accuracy at the time it was written. It may have been superseded by more recent developments. NAM recommends checking whether this is the most current information when making decisions that may affect your health.

NAM’s information is intended to support, rather than replace, consultation with a healthcare professional. Talk to your doctor or another member of your healthcare team for advice tailored to your situation.